...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Intraperitoneal Analgesia Instillation for Postoperative Pain Relief after Laparoscopic Cholecystectomy
【24h】

Intraperitoneal Analgesia Instillation for Postoperative Pain Relief after Laparoscopic Cholecystectomy

机译:腹腔镜胆囊切除术后腹腔注射镇痛药缓解术后疼痛

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Laparoscopic Cholecystectomy (LC) has numerous benefits over the open method; still postoperative pain remains an issue. Postoperative pain, requiring injectable analgesics prolong the patient?s hospital stay, and is one of the hurdles in performing LC as a day-case surgery.Aim: To assess the analgesic effect of Intraperitoneal (IP) administration of Inj. Bupivacaine± Inj. Tramadol in patients undergoing LC.Materials and Methods: A total of 100 patients scheduled for LC were enrolled in the study after meeting the inclusion criteria. Patients were randomly divided into 3 groups. Patient allocated to Group A received 30 mL of inj. normal saline IP, Group B received 30 mL of 0.25% inj. bupivacaine and Group C received 30 mL of 0.25% inj. bupivacaine along with 100 mg inj. tramadol. The local anaesthetic/analgesic or placebo solution was sprayed on the upper surface of the liver and on right subdiaphragmatic space and over gall bladder bed. The pain intensity of pain for patients in all the three groups were recorded using VAS at 0, 1, 2, 6, 12 and 24 hours after surgery. The student t-test was used to compare mean pain score between groups. The p-value =0.05 was taken as significant.Results: There was statistically significant difference in postoperative pain intensity in group A vs groups B (p <0.0001) and also between group A vs group C (p <0.0001) during the first 6 hours postoperatively. But the difference in VAS scores between groups B and C were not statistically significant at all times of postoperative recordings. The addition of inj. tramadol to inj. bupivacaine (group C) IP did not cause a significant reduction in pain compared to bupivacaine only group(group B) but there was increased incidence of Post Operative Nausea and Vomiting (PONV) noted in group C as compared to group B.Conclusion: IP inj. bupivacaine may be used routinely in LC as a part of day-case surgery leading to adequate postoperative pain relief, decreasing need for analgesia and opioids which may lead to early ambulation and initiation of oral feeds, leading to faster postoperative recovery and hence shorter hospital stay, thereby decreasing the burden both to the patient as well as to the hospital.
机译:腹腔镜胆囊切除术(LC)与开放方法相比有很多好处;术后疼痛仍然是一个问题。术后疼痛,需要注射镇痛药,延长患者的住院时间,并且是日间手术进行LC的障碍之一。目的:评估腹膜内(IP)注射Inj的镇痛效果。布比卡因±注射曲马多在接受LC治疗的患者中。材料和方法:符合纳入标准后,共有100名接受LC治疗的患者入选了该研究。将患者随机分为3组。分配到A组的患者接受了30 mL注射液。生理盐水IP,B组接受30 mL的0.25%注射剂量。布比卡因和C组分别接受30 mL的0.25%注射剂量。布比卡因和100毫克注射剂曲马多。将局部麻醉/镇痛药或安慰剂溶液喷洒在肝脏的上表面,右right下间隙和胆囊床上方。在手术后0、1、2、6、12和24小时使用VAS记录三组患者的疼痛疼痛强度。学生t检验用于比较各组之间的平均疼痛评分。 p值= 0.05为显着水平。结果:A组与B组之间的术后疼痛强度差异有统计学意义(p <0.0001),A组与C组之间的疼痛强度也存在统计学差异(p <0.0001)。术后头6个小时。但B组和C组之间的VAS评分差异在术后记录的所有时间均无统计学意义。注射剂的添加。曲马多注射剂与仅布比卡因组(B组)相比,布比卡因(C组)IP并未引起疼痛的明显减轻,但与B组相比,C组注意到手术后恶心和呕吐(PONV)的发生率增加。结论:IP注入。布比卡因可以作为日常手术的一部分在LC中常规使用,从而可以使术后疼痛充分缓解,减少对镇痛和阿片类药物的需求,这可能导致早期下床活动和开始口服喂养,从而使术后恢复更快,从而缩短了住院时间从而减轻了患者和医院的负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号